Bergen senter for etikk og prioritering (BCEPS)


There has not been added a translated version of this content. You can either try searching or go to the "area" home page to see if you can find the information there
Project Funding

BCEPS professor Kjell Arne Johansson receives NOK 12 million in new funding

The Research Council of Norway has awarded NOK 12 million to a 5-year project on "Equity and financial household impact in randomised controlled trials, implementation research and cohort studies in India" (EQUIFINANCE).

Kjell Arne Johansson
Kjell Arne Johanssen -
Ingrid Miljeteig


This project will be led by Kjell Arne and is a collaboration between the Bergen Centre for Ethics and Priority Setting (BCEPS), the Centre for Intervention Science in Maternal and Child Health (CISMAC) at the University of Bergen, the Centre for Health Research and Development, Society for Applied Studies (SAS) in India, and the Translational Health Science and Technology Institute (THSTI), also in India.

The main idea behind EQUIFINANCE is to develop and evaluate new methods to assess equity and economic impact (financial risk protection) of healthcare interventions on households.

Impact on equity and economic return for households of neonatal and child health interventions will be assessed in four high-quality studies:

  • Community-initiated kangaroo mother care (randomised controlled trial - RCT)
  • Zinc supplementation to antibiotic treatment of severe infections (randomised controlled trial - RCT)
  • Integrated community case management of pneumonia (study using implementation research design)
  • High-risk infant follow-up (pregnancy cohort study)

All studies will be conducted in India, and results from the trials are expected to be relevant for SDG 3.8. Extended cost-effectiveness analysis (ECEA), concentration index and curves, and CONSORT-Equity 2017 guidance will be applied and developed.

EQUIFINANCE has a high potential for scientific impact, with the establishment of a leading research group on equity and poverty impact methods in randomised controlled trials, implementation research and cohort studies.